Clinical data | |
---|---|
Routes of administration |
Ingestion, inhalation, intravenous or intramuscular injection |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C16H24N2 |
Molar mass | 244.38 g/mol |
3D model (JSmol) | |
Melting point | 174.5 to 178 °C (346.1 to 352.4 °F) |
|
|
|
|
N,N-Dipropyltryptamine (DPT, also known as "The Light") is a psychedelic drug belonging to the tryptamine family, first reported in 1973. It is found either as its crystalline hydrochloride salt or as an oily or crystalline base. It has not been found to occur naturally. It is a close structural homologue of dimethyltryptamine.
Frequent physical effects are nausea, numbness of the tongue or throat, and pupil dilation.
Studies on rodents have found that the effectiveness with which a selective 5-HT2A receptor antagonist blocks the behavioral actions of this compound strongly suggest that the 5-HT2A receptor is an important site of action for DPT, but the modulatory actions of a 5-HT1A receptor antagonist also imply a 5-HT1A-mediated component to the actions of DPT.
DPT changes Ehrlich's reagent violet and causes the marquis reagent to turn yellow.
While dipropyltryptamine is chemically similar to dimethyltryptamine (DMT), its psychoactive effects are markedly different.
The most prominent features of the DPT experience are increased significance or intensity of music, colors take on a new intensity or appearance, the body may have a buzz or vibratory feeling, a pleasant sensation of warmth, complete ego loss, apparitions of faces.